1
|
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.
|
J Hepatol
|
2013
|
5.64
|
2
|
Risk factors of influenza transmission in households.
|
Br J Gen Pract
|
2004
|
5.25
|
3
|
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.
|
Lancet
|
2009
|
5.03
|
4
|
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
|
N Engl J Med
|
2011
|
4.39
|
5
|
Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
|
Gastroenterology
|
2011
|
3.08
|
6
|
Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
|
Gastroenterology
|
2013
|
2.78
|
7
|
Influenza epidemics in the United States, France, and Australia, 1972-1997.
|
Emerg Infect Dis
|
2004
|
2.37
|
8
|
Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections.
|
J Hepatol
|
2005
|
2.26
|
9
|
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
|
Gut
|
2010
|
1.98
|
10
|
Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.
|
Hepatology
|
2012
|
1.92
|
11
|
Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.
|
Gut
|
2010
|
1.87
|
12
|
Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial.
|
J Am Geriatr Soc
|
2009
|
1.87
|
13
|
Prediction of the spread of influenza epidemics by the method of analogues.
|
Am J Epidemiol
|
2003
|
1.85
|
14
|
Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
|
JAMA
|
2011
|
1.83
|
15
|
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV.
|
AIDS
|
2006
|
1.76
|
16
|
Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.
|
Blood
|
2012
|
1.73
|
17
|
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis.
|
Gastroenterology
|
2005
|
1.67
|
18
|
Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS.
|
Chest
|
2012
|
1.66
|
19
|
Liver biopsy: the best, not the gold standard.
|
J Hepatol
|
2008
|
1.65
|
20
|
Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients.
|
Gastroenterology
|
2002
|
1.56
|
21
|
Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.
|
J Hepatol
|
2010
|
1.51
|
22
|
Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic.
|
BMC Infect Dis
|
2010
|
1.48
|
23
|
Mortality burden of the 1918-1919 influenza pandemic in Europe.
|
Influenza Other Respir Viruses
|
2009
|
1.35
|
24
|
Online detection and quantification of epidemics.
|
BMC Med Inform Decis Mak
|
2007
|
1.33
|
25
|
Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic.
|
PLoS One
|
2012
|
1.29
|
26
|
Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.
|
Am J Trop Med Hyg
|
2010
|
1.28
|
27
|
Transmissibility and geographic spread of the 1889 influenza pandemic.
|
Proc Natl Acad Sci U S A
|
2010
|
1.22
|
28
|
Population modeling of influenza A/H1N1 virus kinetics and symptom dynamics.
|
J Virol
|
2010
|
1.14
|
29
|
Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
|
AIDS
|
2006
|
1.13
|
30
|
Surgical mask to prevent influenza transmission in households: a cluster randomized trial.
|
PLoS One
|
2010
|
1.13
|
31
|
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.
|
Am J Hematol
|
2014
|
1.10
|
32
|
Explaining rapid reinfections in multiple-wave influenza outbreaks: Tristan da Cunha 1971 epidemic as a case study.
|
Proc Biol Sci
|
2011
|
1.10
|
33
|
Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France.
|
J Hepatol
|
2012
|
1.09
|
34
|
The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
|
Value Health
|
2007
|
1.08
|
35
|
Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.
|
J Hepatol
|
2011
|
1.06
|
36
|
Predicting pneumonia and influenza mortality from morbidity data.
|
PLoS One
|
2007
|
1.05
|
37
|
Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt.
|
Hepatology
|
2004
|
1.04
|
38
|
Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.
|
J Hepatol
|
2008
|
1.04
|
39
|
Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.
|
PLoS One
|
2011
|
1.03
|
40
|
Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?
|
J Acquir Immune Defic Syndr
|
2007
|
1.02
|
41
|
Broad respiratory virus detection in infants hospitalized for bronchiolitis by use of a multiplex RT-PCR DNA microarray system.
|
J Med Virol
|
2012
|
1.02
|
42
|
Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY).
|
AIDS
|
2007
|
1.01
|
43
|
Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression.
|
Hepatology
|
2013
|
0.99
|
44
|
Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients.
|
PLoS One
|
2011
|
0.98
|
45
|
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy.
|
J Acquir Immune Defic Syndr
|
2005
|
0.98
|
46
|
Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn's disease: a prospective observational study.
|
Inflamm Bowel Dis
|
2013
|
0.96
|
47
|
Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients.
|
Gut
|
2007
|
0.96
|
48
|
How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited.
|
Clin Chem
|
2008
|
0.96
|
49
|
Detection of lung cancer on radiographs: receiver operating characteristic analyses of radiologists', pulmonologists', and anesthesiologists' performance.
|
Radiology
|
2004
|
0.96
|
50
|
Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort.
|
BMC Public Health
|
2012
|
0.96
|
51
|
Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.
|
PLoS One
|
2011
|
0.94
|
52
|
Intense co-circulation of non-influenza respiratory viruses during the first wave of pandemic influenza pH1N1/2009: a cohort study in Reunion Island.
|
PLoS One
|
2012
|
0.93
|
53
|
Exploring cross-protection between influenza strains by an epidemiological model.
|
Virus Res
|
2004
|
0.93
|
54
|
Assessment and determinants of aesthetic discomfort in hand osteoarthritis.
|
Ann Rheum Dis
|
2011
|
0.92
|
55
|
Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
|
Clin Infect Dis
|
2008
|
0.90
|
56
|
Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population.
|
PLoS One
|
2013
|
0.90
|
57
|
Hepatitis e virus infection in sheltered homeless persons, france.
|
Emerg Infect Dis
|
2012
|
0.89
|
58
|
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2012
|
0.88
|
59
|
Detection of independent associations in a large epidemiologic dataset: a comparison of random forests, boosted regression trees, conventional and penalized logistic regression for identifying independent factors associated with H1N1pdm influenza infections.
|
BMC Med Res Methodol
|
2014
|
0.88
|
60
|
2009 A(H1N1) seroconversion rates and risk factors among the general population in Vientiane Capital, Laos.
|
PLoS One
|
2013
|
0.87
|
61
|
Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey.
|
Ann Rheum Dis
|
2012
|
0.87
|
62
|
Nationwide surveillance of 18 respiratory viruses in patients with influenza-like illnesses: a pilot feasibility study in the French Sentinel Network.
|
J Med Virol
|
2011
|
0.86
|
63
|
Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination.
|
J Immunol
|
2013
|
0.84
|
64
|
Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study.
|
Antivir Ther
|
2009
|
0.84
|
65
|
Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02.
|
Antivir Ther
|
2009
|
0.84
|
66
|
Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study.
|
J Hepatol
|
2010
|
0.82
|
67
|
Age distribution of cases and deaths during the 1889 influenza pandemic.
|
Vaccine
|
2011
|
0.80
|
68
|
Field seasonal influenza vaccine effectiveness: evaluation of the screening method using different sources of data during the 2010/2011 French influenza season.
|
Hum Vaccin Immunother
|
2013
|
0.80
|
69
|
Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study.
|
Eur J Gastroenterol Hepatol
|
2016
|
0.80
|
70
|
Risk perception and priority setting for intervention among hepatitis C virus and environmental risks: a cross-sectional survey in the Cairo community.
|
BMC Public Health
|
2010
|
0.79
|
71
|
Simultaneous investigation of influenza and enteric viruses in the stools of adult patients consulting in general practice for acute diarrhea.
|
Virol J
|
2012
|
0.79
|
72
|
Representations of influenza and influenza-like illness in the community--a qualitative study.
|
BMC Fam Pract
|
2013
|
0.78
|
73
|
Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy.
|
J Hepatol
|
2008
|
0.78
|
74
|
Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: clinical and economic impact.
|
PLoS Curr
|
2009
|
0.78
|
75
|
Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.
|
AIDS
|
2008
|
0.78
|
76
|
Contribution of genome-wide association studies to scientific research: a bibliometric survey of the citation impacts of GWAS and candidate gene studies published during the same period and in the same journals.
|
PLoS One
|
2012
|
0.78
|
77
|
A short-term, multicomponent infection control program in nursing homes: a cluster randomized controlled trial.
|
J Am Med Dir Assoc
|
2012
|
0.78
|
78
|
High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
|
AIDS
|
2007
|
0.78
|
79
|
Determinants of individuals' risks to 2009 pandemic influenza virus infection at household level amongst Djibouti city residents--a CoPanFlu cross-sectional study.
|
Virol J
|
2014
|
0.78
|
80
|
Assessment of healthcare worker influenza vaccination program in French geriatric wards: a cluster-randomized controlled trial.
|
Aging Clin Exp Res
|
2009
|
0.78
|
81
|
Risk factors of pandemic influenza A/H1N1 in a prospective household cohort in the general population: results from the CoPanFlu-France cohort.
|
Influenza Other Respir Viruses
|
2014
|
0.77
|
82
|
Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment.
|
Clin Infect Dis
|
2005
|
0.77
|
83
|
Diagnosis scoring for clinical identification of children with heterozygous familial hypercholesterolemia.
|
J Pediatr Gastroenterol Nutr
|
2009
|
0.77
|
84
|
Characterization of pandemic influenza immune memory signature after vaccination or infection.
|
J Clin Invest
|
2014
|
0.77
|
85
|
Risk of melanoma in patients who receive thiopurines for inflammatory bowel disease is not increased.
|
Am J Gastroenterol
|
2012
|
0.76
|
86
|
Liver fibrosis: screening is not staging.
|
J Hepatol
|
2009
|
0.76
|
87
|
The influenza A (H1N1) pandemic in Reunion Island: knowledge, perceived risk and precautionary behaviour.
|
BMC Infect Dis
|
2013
|
0.76
|
88
|
Response to anti-HCV therapy in HIV-HCV-coinfected patients: does the lipid profile really have an effect?
|
Antivir Ther
|
2010
|
0.76
|
89
|
Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination.
|
Vaccine
|
2003
|
0.76
|
90
|
Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysis.
|
Pharmacoeconomics
|
2003
|
0.76
|
91
|
Heterosubtypic immunity to influenza: right hypothesis, wrong comparison.
|
J Infect Dis
|
2006
|
0.75
|
92
|
Comparing Patients' Opinions on the Hospital Discharge Process Collected With a Self-Reported Questionnaire Completed Via the Internet or Through a Telephone Survey: An Ancillary Study of the SENTIPAT Randomized Controlled Trial.
|
J Med Internet Res
|
2015
|
0.75
|
93
|
Economic evaluations of neuraminidase inhibitors to control influenza.
|
Expert Rev Pharmacoecon Outcomes Res
|
2003
|
0.75
|
94
|
Does nonadherence to local recommendations for empirical antibiotic therapy on admission to the intensive care unit have an impact on in-hospital mortality?
|
Ther Clin Risk Manag
|
2009
|
0.75
|
95
|
Viral pneumonia and respiratory sepsis: association, causation, or it depends?
|
Crit Care Med
|
2007
|
0.75
|
96
|
WTW--an algorithm for identifying "who transmits to whom" in outbreaks of interhuman transmitted infectious agents.
|
J Am Med Inform Assoc
|
2010
|
0.75
|
97
|
Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy.
|
J Acquir Immune Defic Syndr
|
2009
|
0.75
|
98
|
"If you have the flu symptoms, your asymptomatic spouse may better answer the willingness-to-pay question". Evidence from a double-bounded dichotomous choice model with heterogeneous anchoring.
|
J Health Econ
|
2009
|
0.75
|
99
|
Immune activation, smoking, and vaccine response.
|
AIDS
|
2017
|
0.75
|
100
|
Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients.
|
AIDS
|
2008
|
0.75
|
101
|
Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy.
|
Antivir Ther
|
2007
|
0.75
|
102
|
Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests.
|
Clin Chem Lab Med
|
2015
|
0.75
|
103
|
Integrating the applicability rate into the performance evaluation of noninvasive staging of liver fibrosis: a step towards a change from the "accuracy" to the "clinical" paradigm.
|
Clin Res Hepatol Gastroenterol
|
2011
|
0.75
|